The I-GENE project, funded by the European Commission's FET-OPEN call, seeks to develop a groundbreaking technology for precise and efficient gene editing by leveraging nanomedicine and programmable biology. Our goal is to overcome the major limitations of CRISPR/Cas9 technology, including target sp...See more
Headquarters:
Italy
Company Type:
SME
Company size:
1-10 Employees
Address:
VIA ALESSANDRO VOLTA; UNIVERSITÀ DI PISA DEPARTMENT OF BIOLOGY; PISA, TOSCANA 56126, IT
LOW
spending power